CSA Antisense Targeting Enhances Anticancer Drug Sensitivity in Breast Cancer Cells, including the Triple-Negative Subtype

SIMPLE SUMMARY: Breast cancer (BC), the most frequent malignancy in woman, shows a high rate of cancer recurrence and resistance to treatment, particularly in Triple-Negative Breast Cancer (TNBC) subtype. Starting from the observation that different subtypes of BC cells, including the TNBC one, disp...

Descripción completa

Detalles Bibliográficos
Autores principales: Filippi, Silvia, Paccosi, Elena, Balzerano, Alessio, Ferretti, Margherita, Poli, Giulia, Taborri, Juri, Brancorsini, Stefano, Proietti-De-Santis, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997023/
https://www.ncbi.nlm.nih.gov/pubmed/35406459
http://dx.doi.org/10.3390/cancers14071687

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997023/
https://www.ncbi.nlm.nih.gov/pubmed/35406459
http://dx.doi.org/10.3390/cancers14071687

Ejemplares similares